黑龙江江世药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
65
NMPA:65
Drug Approvals
Ethylenediamine Diaceturate for Injection
- Product Name
- 注射用二乙酰氨乙酸乙二胺
- Approval Number
- 国药准字H20050520
- Approval Date
- Aug 27, 2023
NMPA
Carbamide Peroxide for injection
- Product Name
- 注射用过氧化碳酰胺
- Approval Number
- 国药准字H20053360
- Approval Date
- Aug 27, 2023
NMPA
Potassium Aspartate and Magnesium Aspartate Injection
- Product Name
- 门冬氨酸钾镁注射液
- Approval Number
- 国药准字H20045489
- Approval Date
- Aug 27, 2023
NMPA
Polysacharidum of G.Lucidum Karst for Injection
- Product Name
- 注射用赤芝孢子多糖
- Approval Number
- 国药准字H20051702
- Approval Date
- Aug 27, 2023
NMPA
Xantinol Nicotinate Injection
- Product Name
- 烟酸占替诺注射液
- Approval Number
- 国药准字H20033454
- Approval Date
- Aug 27, 2023
NMPA
Fructose Sodium Diphosphate Injection
- Product Name
- 果糖二磷酸钠注射液
- Approval Number
- 国药准字H20044931
- Approval Date
- Aug 27, 2023
NMPA
Sodium New Houttuyfonate Injection
- Product Name
- 新鱼腥草素钠注射液
- Approval Number
- 国药准字H20046081
- Approval Date
- Aug 11, 2023
NMPA
Meglumine Adenosine Cyclophosphate Injection
- Product Name
- 环磷腺苷葡胺注射液
- Approval Number
- 国药准字H20044389
- Approval Date
- Dec 7, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found